Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.7 USD | +1.42% | -2.40% | -38.44% |
May. 31 | Clarivate Partners With HealthWise Data to Enhance Patient Insights | MT |
May. 21 | The latest transactions by star managers |
Financials (USD)
Sales 2024 * | 2.61B | Sales 2025 * | 2.67B | Capitalization | 3.81B |
---|---|---|---|---|---|
Net income 2024 * | -93M | Net income 2025 * | 14M | EV / Sales 2024 * | 3.31 x |
Net Debt 2024 * | 4.83B | Net Debt 2025 * | 4.33B | EV / Sales 2025 * | 3.04 x |
P/E ratio 2024 * |
-38.4
x | P/E ratio 2025 * |
363
x | Employees | 12,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.15% |
Latest transcript on Clarivate Plc
1 day | +1.42% | ||
1 week | -2.40% | ||
1 month | -17.87% | ||
3 months | -20.17% | ||
6 months | -29.02% | ||
Current year | -38.44% |
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Gear
CEO | Chief Executive Officer | 53 | 22-07-10 |
Jonathan Collins
DFI | Director of Finance/CFO | 44 | 21-12-15 |
William Graff
CTO | Chief Tech/Sci/R&D Officer | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jerre Stead
BRD | Director/Board Member | 81 | 19-04-30 |
Anthony Munk
BRD | Director/Board Member | 63 | 16-09-30 |
Richard Roedel
BRD | Director/Board Member | 74 | 20-05-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
12.89% | 254 M€ | +13.69% | - | |
0.71% | 14 M€ | +3.72% | ||
0.67% | 3 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 5.7 | +1.42% | 7,245,804 |
24-05-30 | 5.62 | -0.18% | 8,397,665 |
24-05-29 | 5.63 | -4.74% | 4,075,569 |
24-05-28 | 5.91 | +1.20% | 4,036,379 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.44% | 3.81B | |
+21.07% | 77.46B | |
-12.46% | 39.23B | |
+13.48% | 37.74B | |
-6.43% | 28.6B | |
-15.26% | 15.41B | |
+4.67% | 13.97B | |
+10.17% | 10.44B | |
-18.03% | 4.25B | |
+19.10% | 2.32B |
- Stock Market
- Equities
- CLVT Stock